|Articles|April 22, 2021

SARS-CoV-2 Virus Found to Inflict Damage but Not Infect Brain

Author(s)Killian Meara

While no evidence of any viral RNA was detected in patients brain cells, investigators found a significant amount of neurological damage.

A recent study conducted by investigators from the Columbia University Irving Medical Center has found that SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain, but is still able to inflict a significant amount of neurological damage.

Results from the study were published in the journal Brain.

"There's been considerable debate about whether this virus infects the brain, but we were unable to find any signs of virus inside brain cells of more than 40 COVID-19 patients," James E. Goldman, lead author on the study said. "At the same time, we observed many pathological changes in these brains, which could explain why severely ill patients experience confusion and delirium and other serious neurological effects--and why those with mild cases may experience 'brain fog' for weeks and months."

For the study, investigators examined 41 patients who died because of COVID-19 during a hospitalization. Of the patients, ages ranged between 38 and 97 years of age, around half had been intubated and all of the patients had some form of lung damage.

The investigators performed multiple types of testing on more than 2 dozen brain regions, including RNA in situ hybridization and RT-PCR, to try and detect any viral RNA within intact cells in the brain, but found no evidence of any being there.

While no viral RNA was detected, the investigators found a significant amount of brain pathology, including areas of stroke and a large amount of microglia, a type of immune cell that resides in the brain.

Most of the immune cells were found in the lower brain stem, an area which is known to regulate heart and breathing rhythms and levels of consciousness.

"We've looked at more brains than other studies, and we've used more techniques to search for the virus. The bottom line is that we find no evidence of viral RNA or protein in brain cells," Goldman said. "Though there are some papers that claim to have found virus in neurons or glia, we think that those result from contamination, and any virus in the brain is contained within the brain's blood vessels."


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.